Welcome to the leading edge of gene therapy education

The mission of the GT Network is to provide healthcare professionals with high quality, scientific information about gene therapy

homepagedna.svg

MODULE 1

Overview of Gene Therapy

An overview of gene therapy and some of the key concepts in this field

MODULE 2

Monogenic and Complex Diseases

An overview of genetic abnormalities and current treatment strategies for monogenic diseases

MODULE 3

Safety of Gene Therapy

A review of the two types of immune responses in the context of two of the most widely studied viral vectors

MODULE 4

Practical Considerations

An overview of the biological risks and containment practices for use of AAV-based gene therapies

MODULE 5

Gene Replacement

One important approach to gene therapy is gene replacement. This video further explores this important concept.

MODULE 6

Current Therapeutics & Research

A review of the gene therapy development landscape and exploration of marketed agents

NEWS

STEERING COMMITTEE

Meet our multidisciplinary, internationally renowned steering committee of experts:

GTNSteering-jenkins
Chris Jenkins, PhD, MPH
Chairperson
Principal Partner and Chief Gene Therapy Biosafety Officer at Clinical Biosafety Services

GTNSteering-goebel
Diana Bharucha-Goebel, MD
Director of the Muscular Dystrophy Association Care Center and Assistant Professor in the Division of Neurology

GTNSteering-burghes
Arthur Burghes, PhD
Professor at Wexner Medical Center College of Medicine in the Department of Biological Chemistry and Pharmacology

James Dowling, MD, PhD, FANA
Professor of Pediatrics and Molecular Genetics at the University of Toronto

Uta Griesenbach, DIPL-BIOL, PhD
Professor in Molecular Medicine at the National Heart and Lung Institute at Imperial College London

GTNSteering-petrich
John Petrich, MS, RPh
Director Investigational Drug Services at the Cleveland Clinic